Viracta Therapeutics Inc

General ticker "VIRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $7.0M

Viracta Therapeutics Inc does not follow the US Stock Market performance with the rate: -35.1%.

Estimated limits based on current volatility of 7.2%: low 0.21$, high 0.25$

Factors to consider:

  • Current price 38.3% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.38$, 1.27$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.51$, 1.46$]

Financial Metrics affecting the VIRX estimates:

  • Negative: Non-GAAP EPS, $ of -1.32 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -67.99 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term VIRX quotes

Long-term VIRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $13.76MM $0.00MM $0.00MM
Operating Expenses $128.03MM $50.59MM $50.69MM
Operating Income $-114.28MM $-50.59MM $-50.69MM
Non-Operating Income $-1.23MM $2.61MM $-0.54MM
Interest Expense $0.49MM $0.58MM $3.70MM
R&D Expense $23.86MM $26.26MM $33.37MM
Income(Loss) $-115.50MM $-47.98MM $-51.24MM
Profit(Loss) $-115.50MM $-47.98MM $-51.24MM
Stockholders Equity $94.37MM $61.10MM $18.32MM
Inventory $0.00MM $0.91MM $0.14MM
Assets $108.55MM $95.99MM $56.69MM
Operating Cash Flow $-18.85MM $-35.46MM $-39.89MM
Capital expenditure $4.25MM $0.04MM $0.14MM
Investing Cash Flow $12.89MM $-53.87MM $15.00MM
Financing Cash Flow $62.42MM $22.54MM $0.44MM
Earnings Per Share* $-6.37 $-1.32 $-1.32

* EPS are Split Adjusted, recent splits may be reflected with a delay.